Aphria Posts Revenues of $160.5 Million, Loss Of $120.6 million In Q2 2020

Aphria Inc (TSX: APHA) (NASDAQ: APHA) this morning reported its second quarter financial results for 2021, reporting net revenues of $160.5 million, while posting a net loss of $120.6 million. Included in the significant loss was $87.6 million related to an unrealized loss on convertible debentures, as well as transaction costs of $22.6 million and share based compensation of $13.6 million.

Net revenue improved on a quarter over quarter basis, with the firm seeing revenues rise from the $145.7 million reported last quarter to $160.5 million. Included in the revenue figure was improving cannabis revenues, which hit $67.9 million on a net basis, as compared to $63.5 million in the prior quarter. Distribution revenues also improved, climbing from $82.2 million to $91.7 million. Beverage alcohol revenue meanwhile, a function of the SweetWater transaction, came in at $0.9 million.

Despite the rise in revenues, gross profit fell from the prior quarters $43.3 million to $39.5 million. Operating expenses meanwhile came in at $82.7 million, a significant increase from the $54.5 million reported in the first quarter of 2021.

General and administrative expenses fell to $27.8 million during the quarter, down from $28.4 million previously. Selling expenses meanwhile rose marginally to $7.5 million from $7.2 million, while marketing and promotion fell to $5.3 million from $6.1 million. The largest change in terms of expenses was share based compensation, which rose from $4.3 million to $13.6 million, while transaction costs climbed from $3.0 million to $22.6 million.

In terms of other expenses, the company saw financing expenses fall from $7.2 million to $6.1 million. However, the company took a large charge in terms of non-operating expenses, which grew from $17.3 million to $89.8 million, which assisted in propelling the company to a net loss of $120.6 million, compared to a loss of $5.1 million last quarter.

Looking to the balance sheet, Aphria saw its cash and cash equivalents tumbled from $400.0 million to $188.0 million, a function of the $341.8 million paid on business acquisitions. This was however partially offset by the receipt of nearly $127.5 million in cash proceeds from the issuance of share capital.

Accounts receivable meanwhile climbed to $96.2 million, up from $82.5 million, while inventory was effectively flat at $321.5 million. Prepaids fell marginally from $51.3 million to $48.2 million. Overall, total current assets declined from $891.5 million to $692.1 million.

Current liabilities meanwhile skyrocketed northward, with accounts payable more than doubling from $124.4 million to $254.3 million. Bank indebtedness fell however, declining from $7.9 million to $5.1 million, while income taxes payable fell from $21.6 million to $16.6 million. Current portion of long term debt meanwhile climbed from $10.8 million to $15.2 million. Overall, total current liabilities climbed from $166.0 million to $293.0 million.

That significant climb in payables is also likely why the company closed a US$120 million financing with BMO, consisting of a $20 million revolver and the remainder being classified as term debt.

The company did not provide guidance within its release this morning.

Aphria Inc last traded at $12.70 on the TSX.


Information for this briefing was found via Sedar and Aphria Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

First Majestic Q3 Earnings: Another RECORD Quarter!

Barrick Q3 Earnings: Juicing Shareholder Returns Amid Declining Production

Wheaton Q3 Earnings: Cash Operating Margins Skyrocket

Recommended

Goliath Resources Extends High Grade Zone To 580 Metres In Latest Assays

Emerita Resources Hits 2.7% Copper, 1.85 g/t Gold Over 9.6 Metres At El Cura

Related News

Aphria: Canaccord Downgrades Company To Hold From Speculative Buy

Earlier this week, it was announced that Aphria Inc (TSX: APHA) (NASDAQ: APHA) and Tilray...

Friday, December 18, 2020, 12:05:00 PM

The Reality of Aphria’s 2020 $1 Billion Canadian Cannabis Sales Run Rate Guidance

This morning, Aphria Inc (TSX: APHA) (NYSE: APHA) reaffirmed on its conference call that the...

Tuesday, October 15, 2019, 08:18:42 PM

Tilray & Aphria: The Analyst Perspective

This morning it was announced that Aphria Inc (TSX: APHA) (NASDAQ: APHA) and Tilray Inc...

Wednesday, December 16, 2020, 02:04:02 PM

Liberty Health Sciences Sells Florida Greenhouse, Land and Ohio Assets for $14.75M

Tonight Liberty Health Science (CSE: LHS) announced the Company is selling 36 acres of land,...

Monday, August 19, 2019, 11:48:31 PM

Aphria, Tilray Announce $5 Billion Merger Justified By Topline Revenues

Well it appears the rumours have finally come to fruition when it comes to Aphria...

Wednesday, December 16, 2020, 07:39:40 AM